Ambea AB ( publ ) (“Ambea”) declared the public takeover offer for Humana AB (“Humana” or the “Company”) unconditional on 1 October 2026. Ambea controls more than 90 per cent of the shares in Humana and has announced its intention to squeeze out the remaining shares in the Company.
At the request of Ambea, the Board of Directors of Humana has today resolved to apply for the delisting of the Company’s shares from Nasdaq Stockholm. The last day of trading in the Company’s shares on Nasdaq Stockholm will be announced as soon as the Company has received confirmation from Nasdaq Stockholm.
At the request of Ambea, the Board of Directors of Humana has further today resolved to convene an Extraordinary General Meeting to be held on 30 October 2026 for the purposes of, among other things, the election of new board members.
For more information, please contact:
Ewelina Pettersson
Head of Investor Relations
+4673 074 79 12
ewelina.pettersson@humana.se